C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/08 (2006.01) A61K 31/4995 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2559917
A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.
L'invention concerne un composé de formule (I), y compris un sel ou un ester pharmaceutiquement acceptable correspondant. Les symboles de la formule ont l'acception définie dans la description. Ce type de composé, antagoniste vis-à-vis du CCR-1, est utilisable dans les applications pharmaceutiques pour le traitement des maladies et des affections faisant intervenir le CCR-1, par exemple en liaison avec les maladies inflammatoires.
Heng Richard
Revesz Laszlo
Schlapbach Achim
Waelchli Rudolf
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Compounds as ccri antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds as ccri antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds as ccri antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1540927